Sort
15,842 grants matching “pancreatic cancer”
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer
$278,912Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · P50 · FY2010 · CA
TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER
$278,768David J Cole · Medical University Of South Carolina · R01 · FY2008 · CA
TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER
$278,768David J Cole · Medical University Of South Carolina · R01 · FY2010 · CA
TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER
$278,768David J Cole · Medical University Of South Carolina · R01 · FY2009 · CA
The Antigen Targeting Core
$278,764Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers
$278,737Suresh T. Chari · Mayo Clinic Rochester · P50 · FY2011 · CA
Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells
$278,675Carl H. June · University Of Pennsylvania · R01 · FY2006 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery
$278,595Michael Bouvet · University Of California, San Diego · R01 · FY2013 · CA
Preclinical Therapeutics
$278,555Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2015 · CA
The Role of COX-2 and PPAR-Gamma in Pancreatic Cancer
$278,354Guido Erwin Michael Eibl · University Of California Los Angeles · R01 · FY2006 · CA
Refined Fructose Promotes Pancreatic Cancer Growth
$278,340Anthony P Heaney · University Of California Los Angeles · R01 · FY2008 · CA
Refined Fructose Promotes Pancreatic Cancer Growth
$278,340Anthony P Heaney · University Of California Los Angeles · R01 · FY2010 · CA
Refined Fructose Promotes Pancreatic Cancer Growth
$278,340Anthony P Heaney · University Of California Los Angeles · R01 · FY2009 · CA
Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2)
$278,189Robert Loberg · University Of Michigan At Ann Arbor · P50 · FY2008 · CA
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer
$278,115Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · P50 · FY2012 · CA
In Vivo Imaging, Dosimetry and Technology Transfer
$278,089Brian William Pogue · Massachusetts General Hospital · P01 · FY2009 · CA
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
$278,002Amato J. Giaccia · Stanford University · P01 · FY2010 · CA
Radiofrequency Remote Control of Enzyme-Nanocluster Conjugates
$277,987Christopher Jeffries Ackerson · Colorado State University · R01 · FY2017 · GM
Molecular Regulation of Folate and Antifolate Transport
$277,970Larry H. Matherly · Wayne State University · R01 · FY2024 · CA
Autoantibodies Against Glycopeptide Epitopes as Serum Biomarkers of Cancer
$277,966Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2011 · CA
Chromosome inverted fusions, dicentrics and genome instability
$277,941Ted A. Weinert · University Of Arizona · R01 · FY2013 · GM
Defining Secreted Glycan Alterations in Pancreatic Cancer
$277,884Brian B Haab · Van Andel Research Institute · R33 · FY2010 · CA
The Role of MicroRNAs in Cellular Quiescence
$277,727Hilary A Coller · Princeton University · R01 · FY2010 · GM
REGULATION OF AURORA-A KINASE ACTIVITIES BY AURORA-A INTERACTING PROTEINS
$277,355Ming-Ying Tsai · University Of Nebraska Medical Center · P20 · FY2009 · RR
1/2: Partnership to study racial/ethnic differences in GI cancer biology
$277,311Ellen Li · State University New York Stony Brook · P20 · FY2018 · CA